Related Experiment Video
Updated: Jul 11, 2025

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
Graph-based multi-modality integration for prediction of cancer subtype and severity.
Diane Duroux1,2, Christian Wohlfart3, Kristel Van Steen4,5
1BIO3 - Systems Genetics, GIGA-R Medical Genomics, University of Liège, 4000, Liège, Belgium. diane.duroux@ai.ethz.ch.
Personalized cancer screening using graph theory and multi-omics data improves diagnostic accuracy. Integrating RNA-Seq and histopathology data via graph-based fusion enhances prediction of cancer subtypes and severity.
Area of Science:
- Computational biology
- Bioinformatics
- Cancer research
Background:
- Personalized cancer screening requires integrating diverse data types for improved accuracy.
- Current methods often analyze single data sources, neglecting valuable interactions and complementary insights.
Purpose of the Study:
- To develop and evaluate a graph-theory-based approach for integrating multi-omics data (RNA-Seq, histopathology) for personalized cancer screening.
- To assess the impact of different data fusion strategies (early, intermediate, late) on predicting cancer subtypes and severity.
Main Methods:
- Construction of individual-specific networks using RNA-Seq and whole-slide imaging data.
- Computation of inter-individual similarity matrices based on graph structures.
- Training and evaluation of classification models using similarity matrices and macro F1 score.
Main Results:
- Graph-based methods demonstrate improved performance over non-interaction-aware approaches.
- Multi-modal data integration, particularly through intermediate fusion, enhances classification accuracy compared to single-data models.
- The proposed workflow shows adaptability and potential for personalized healthcare applications.
Conclusions:
- Graph theory provides a powerful framework for integrating multi-modal data in personalized cancer screening.
- Intermediate fusion of RNA-Seq and histopathology data offers significant advantages for cancer subtype and severity prediction.
- The developed methodology holds promise for advancing personalized medicine across various disease contexts.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
06:32Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023